Benefit of BM-MSC addition in core decompression in treatment of osteonecrosis of the femoral head
Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: A meta-analysisInt J Surg. 2019 Jul 10;69:23-31
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
14 randomized controlled trials were included in this meta-analysis which sought to investigate the impact of autologous bone marrow-derived mesenchymal stem cell (MSC) administration alongside core decompression on outcomes in treatment of patients with osteonecrosis of the femoral head. Pooled analyses of pain scores from 6 months to 2 years, function from 1 to 2 years, and incidence of eventual...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE